Hyponatremia in Guillain-Barré Syndrome

J Clin Neuromuscul Dis. 2017 Jun;18(4):207-217. doi: 10.1097/CND.0000000000000157.

Abstract

Objectives: To evaluate incidence, risk factors, and in-hospital outcomes associated with hyponatremia in patients hospitalized for Guillain-Barré Syndrome (GBS).

Methods: We identified adult patients with GBS in the Nationwide Inpatient Sample (2002-2011). Univariate and multivariable analyses were used.

Results: Among 54,778 patients hospitalized for GBS, the incidence of hyponatremia was 11.8% (compared with 4.0% in non-GBS patients) and increased from 6.9% in 2002 to 13.5% in 2011 (P < 0.0001). Risk factors associated with hyponatremia in multivariable analysis included advanced age, deficiency anemia, alcohol abuse, hypertension, and intravenous immunoglobulin (all P < 0.0001). Hyponatremia was associated with prolonged length of stay (16.07 vs. 10.41, days), increased costs (54,001 vs. 34,125, $USD), and mortality (20.5% vs. 11.6%) (all P < 0.0001). In multivariable analysis, hyponatremia was independently associated with adverse discharge disposition (odds ratio: 2.07, 95% confidence interval, 1.91-2.25, P < 0.0001).

Conclusions: Hyponatremia is prevalent in GBS and is detrimental to patient-centered outcomes and health care costs. Sodium levels should be carefully monitored in high-risk patients.

MeSH terms

  • Adolescent
  • Adult
  • Age Distribution
  • Aged
  • Female
  • Guillain-Barre Syndrome / complications*
  • Guillain-Barre Syndrome / economics
  • Guillain-Barre Syndrome / epidemiology*
  • Guillain-Barre Syndrome / therapy
  • Health Care Costs / statistics & numerical data
  • Humans
  • Hyponatremia / economics
  • Hyponatremia / epidemiology*
  • Hyponatremia / etiology*
  • Immunoglobulins, Intravenous / therapeutic use
  • Incidence
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Prevalence
  • Retrospective Studies
  • Young Adult

Substances

  • Immunoglobulins, Intravenous